Синдром диссеминированного внутрисосудистого свертывания крови - Макацария А.Д.
ISBN 5-8249-0078-7
Скачать (прямая ссылка):
263. Muller-Berghaus G., Cate Y.N., Levi M. Disseminated intravascular coagulation: clinical spectrum and established as well a new approach.//Nromb. haemost 1999,-82(2),-p.706-712.
264. Murphy N., Fitzerald DJ. Integrin regulation of COX activity.// Thromb.a Haemost.,-1997, suppl.,- P.667-667.
265. Nadesan K, Jayalakshmi P: Sudden maternal deaths from amniotic fluid embolism. Ceylon Medical Journal 42:185,1997
266. Nauyn B Unterschungen Ober Blutgerinnung I.M. Lebenden Tiere und Ihre Folgen Arch Exp Pathol Pharmak 1873; 1:1.
267. Newton M Amniotic fluid embolism: the nonfatal case. J Miss State Med Assoc 1966; 7:607.
268. Nieuwiand R, van Egmond S.AJ., Sturk A. Endothelial cell-derived mi-croparticles are procoagulant.//Thromb. Haemost,-1999-9.-p.95-95.
269. Niewiarowski S, Stuart RK, Thomas DP, Activation of intravascular coagulation by collagen. Proc Soc Exp Biol Med 1966; 123:196.
270. O'Boyle JD, Magann EF, Waxman E, et al: Dexamethasone facilitated postponement of delivery of an extremely preterm pregnancy complicated by the syndrome of hemolysis, elevated liver enzymes, and low platelets. Mil Med 164:316, 1999
271. Oi H1 Kobayashi H, Hirashima Y, et al: Serological and immunohis-tochemical diagnosis of amniotic fluid embolism. Semin Thromb Hemost 24:479, 1998
491
272. Okajima К, Uchiba M, Murakami К, et al: Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulation. AmJ Hematol 54:219, 1997
273. Okajima K, Fujise R, Motosato Y, et al: Plasma levels of granulocyte elastase-alpha 1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: Pathophysiologic implications. AmJ Hematol 47:82, 1994
274. Okamoto K, Takaki A, Takeda S, et al: Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: Determination of prothrombin fragment 1+2 and other markers. Haemostasis22:17,1992
275. Ono S, Mochizuki H, Tamakuma S: A clinical study on the significance of platelet-activating factor in the pathophysiology of seph'c disseminated intravascular coagulation in surgery. AmJ Surg 171:409,1996
276. Owen CA, Bowie EJW, Cooper HA: Turnover of fibrinogen and platelets in dogs undergoing induced intravascular coagulation.
Thromb Res 2:251,1973
277. Page EW, Fulton LD, Glendening MB The cause of the blood coagulation defect following ab-ruptio placentae Am J Obstet Cynecol 1951; 61:1116
278. Paternoster DM. Rod! J, Santarossa C, et al: Acute pancreatitis and deep vein thrombosis associated with the HELLP syndrome. Min Ginecol 51:31, 1999
279. Patterson VVP, Ringenberg QS: The pnthophysiology of thrombosis in cancer. Semin Oncol 17:140,1990
280. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 65:153, 1991
281. Petroianu GA, Altmannsberger SH, Maleck WII, et al: Meconium and amniotic fluid embolism: Effects on coagulation in pregnant mini-pigs. Crit Care Med 27:348, 1999
282. Phillips LL, Skodclis V, Quigley HJ. Intravascular coagulation and fibnnolysis in septic abortion. Obtet Gynecol 1967; 30:350
283. Pineo GF, MC Brain, AS Gallus: Tumors, mucus production, and hypercoagulability. Ann N Y Acad Sei 230:262,1974
284. Plow EF, Edgington TS: Surface markers of fibrinogen and its physiologic derivatives related by antibody probes. Semin Thromb Hemost8:36, 1982
285. Porozhanova V, Bozhinova S, Khristova V: The perinatal outcome in adolescents with eclampsia and the HELLP syndrome. Akush Ginekol (Sofia) 35:14, 1996
286. Portis R, Jacobs MA, SkermanJH, et al: HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) pathophysiology and anesthetic considerations. American Association of Nurse Anesthetists Journal 65:37, 1997
492
287. Preston F.E., Rosendaal F.R., Walker J.D. Thromboprophylaxis in pregnancy reduces fetal losses in women with heritable thrombophilia: a prospect study .//Thromb. Hemost.,- 1999.-9.-p.227-227.
288. Pusey ML, Mende TJ: Studies on the procoagulant activity of human amniotic fluid L Stability and coagulation factor requirements. Thromb Res 39:355,1985
289. Pusey ML, Meride TJ: Studies on the procoagulant activity of human amniotic fluid II. The role of factor VIL Thromb Res. 39:571,1985
290. Rapaport SL Defibrination syndromes. In: Williams WJ, Beutler E, Erslev AJ, Rundles WR, eds. Hematology, 2nd ed. New York McGraw-Hill, 1977.
291. Ratnoff OD, Nebehay WG. Multiple coagulative defects in a patient with the Waterhouse-Friderichsen syndrome. Ann Intern Med 1962; 56:627
292. Rath W: Aggressive versus conservative management of HELLP syndrome A status assessment. Geburtshilfe und Frauenheilkunde 56:265, 1996
293. Regoeczi E, Brain MC. Organ distribution of fibrin in DIC BrJ Haematol 1969; 17:73
294. Robson S, Shephard E, Kirsch R: Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-I beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. BrJ Haematol 86:322,1994
